Correlation Between Milestone Pharmaceuticals and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Neurobo Pharmaceuticals.
Diversification Opportunities for Milestone Pharmaceuticals and Neurobo Pharmaceuticals
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Neurobo is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.71 times more return on investment than Neurobo Pharmaceuticals. However, Milestone Pharmaceuticals is 1.41 times less risky than Neurobo Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 406.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would lose (219.00) from holding Milestone Pharmaceuticals or give up 53.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Neurobo Pharmaceuticals |
Milestone Pharmaceuticals and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Neurobo Pharmaceuticals
The main advantage of trading using opposite Milestone Pharmaceuticals and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.The idea behind Milestone Pharmaceuticals and Neurobo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |